Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533955) titled 'A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis' on April 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).
Primary Sponsor: Jade Biosciences, Inc.
Condition:
Rhematoid Arthritis
Intervention:
Drug: JADE201
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: May 2026
Target Sample Size: 36
Countries of Recruitment:
Moldova
Ukraine
Moldova
Ukraine
To know more, visit https://clinicaltrials.gov/study/NCT07533955
Disclaim...